MD Anderson recently announced an agreement with Hospital Israelita Albert Einstein (HIAE) in São Paulo, Brazil, creating an alliance to develop a comprehensive, multidisciplinary oncology program at the hospital.
The 10-year agreement calls for MD Anderson to provide its specialized expertise to help transform HIAE’s oncology program into the premier cancer care center in South America. It will focus on four key initiatives: patient care, research, education and prevention ― obviously in line with MD Anderson’s own mission areas.
Brazil, which reports more than 520,000 new cancer cases a year, represents an opportunity to make a significant and lasting impact on cancer care delivery, says Amy Hay, interim vice president for global business development.
“Hospital Israelita Albert Einstein will incorporate MD Anderson’s multidisciplinary approach to address the cancer burden in Brazil, and MD Anderson will advance its mission by extending its reach to South America,” says Hay. “Most important, patients in Brazil will have a powerful force to aid in their fight against cancer.”
The agreement represents an expansion of a long-standing relationship between the two institutions. HIAE became MD Anderson’s first formal sister institution in 2002, leading to frequent academic exchanges. Prior agreements between MD Anderson and HIAE, starting in 2008, have resulted in the launch of multidisciplinary breast and genitourinary clinics, as well as a redesign of oncology facilities at the HIAE.